Journal
HEALTH AFFAIRS
Volume 27, Issue 6, Pages 1600-1611Publisher
PROJECT HOPE
DOI: 10.1377/hlthaff.27.6.1600
Keywords
-
Ask authors/readers for more resources
An ongoing dilemma in genomic medicine is balancing the need for scientific innovation with appropriate evidence thresholds for moving technology into practice. The current low threshold allows unsubstantiated technologies to enter into practice, with the potential to overwhelm the health system. Alternatively, establishing an excessively high threshold for evidence could slow the integration of genomics into practice and present disincentives for investing in research and development. Also, variable coverage and reimbursement policies can lead to differential access to technology, exacerbating health disparities. There is an urgent need for a collaborative process for appropriate transition of genomic discoveries from research to practice. [Health Affairs 27, no. 6 (2008): 1600 1611; 10.1377/hlthaff.27.6.1600]
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available